Патогенетичні механізми функціональних порушень тромбоцитів за умов прогресування хронічної ішемії головного мозку

Фактори ризику порушення мозкового кровообігу та предиктори прогресування хронічної ішемії головного мозку. Медикаментозна терапія хворих з дисциркуляторною енцефалопатією. Функціональний стан тромбоцитів на фоні стандартної медикаментозної терапії.

Рубрика Медицина
Вид диссертация
Язык украинский
Дата добавления 26.06.2018
Размер файла 745,4 K

Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже

Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.

64. Arnan M.K. Secondary prevention of stroke in the elderly: focus on drug therapy/ M.K. Arnan, G.L. Burke, C. Bushnell // Drugs Aging. - 2014. - Vol. 31(10) - Р. 721-730.

65. Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance / G.A. Roth, C.W. Gillespie, A.A. Mokdad [et al.] // BMC Cardiovasc Disord. - 2014. - Vol. 7(14). - Р. 16.

66. Auriel E. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system / E. Auriel, K. Regev, A.D. Korczyn // Handb Clin Neurol. - 2014. - Vol. 119. - Р. 577-584.

67. Avula R. Simultaneous genotyping of multiplepolymorphisms in human serotonin transporter gene and detection of novel allelic variants / R. Avula, A. Rand, J. Black // Transl Psychiatry. - 2011. - Vol. 1. - С. 32 - 37.

68. Battinelli E. M. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis / E. M. Battinelli, B.A. Markens, J.E. Italiano // Blood. - 2011. - Vol. 118(5). - Р. 1359-1369.

69. Blood-brain barrier damage in vascular dementia / M. Ueno, Y. Chiba, K. Matsumoto [et al.] // Neuropathology. -2015. - doi. - 10.1111/neup.12262.

70. Burden of intracranial steno-occlusive lesions on initial computed tomography angiography predicts poor outcome in patients with acute stroke / A. Y. Lau, K. S. Wong, M. Lev [et al.] // Stroke. - 2013. - Vol. 44(5). - P. 1310-1316.

71. Chabriat H. Vascular dementia: potential of antiplatelet agents in prevention / H. Chabriat, M.G. Bousser [et al.] // Eur Neurol.- 2006. - Vol. 55(2). - Р. 61- 69.

72. Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke / M. Lukasik, G. Dworacki, S. Michalak [et al.] // Platelets. - 2012. - Vol. 23(2). - Р. 132-142.

73. Clauss R. Disorders of consciousness and pharmaceuticals that act on oxygen based amino acid and monoamine neurotransmitter pathways of the brain/ R. Clauss // Curr Pharm Des. - 2014. - Vol. 20(26). - Р. 4140-4153.

74. Clinical predictors of lacunar syndrome not due to lacunar infarction / A. Arboix, J. Massons, L. Garcнa-Eroles [et al.] // BMC Neurol. - 2010. - Vol. 10. - P. 31-37.

75. Computed tomography identifies patients at high risk for stroke after transient ischemic attack/nondisabling stroke: prospective, multicenter cohort study/ J.K. Wasserman, J.J. Perry, M.L. Sivilotti [et al.] // http://www.ncbi.nlm.nih.gov/pubmed/25477216- 2015.- Vol. 46(1).- Р.114-119.

76. Dambisya Y. M. Effects of the platelet-activating factor receptor antagonist WEB2086 on whole blood coagulation and fibrinolysis in a thromboelastography assay. / Y. M. Dambisya., T. L. Lee, I. M. Hussaini // Blood Coagul Fibrinolysis. - 1995. - Vоl. 6 (8). - Р. 733-777.

77. De Miguel A. Clinical implications of clopidogrel resistance / A. De Miguel, B. Ibanez, J. Badimуn // Thromb. Haemost. - 2008. - Vol. 100. - P. 196-203.

78. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Strokeand Monitoring for PAF in Real Time (SMART) Registry / A.C. Flint, N.M Banki, X. Ren [et al.] // Stroke. - 2012. - Vol. 43 (10). - Р. 2788-2790.

79. Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay / M. Papen, S. Gambaryan, C. Schьtz [et al.] // Transfus Med Hemother. - 2013. - Vol. 40(2). - Р. 109-116.

80. Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets / T.M. Quinton ., S. Murugappan, S. Kim [et al.] // J Thromb Haemost. - 2004. - Vol. 2(6). - Р. 978 - 984.

81. Disruption of IP3R2-mediated Ca(2+) signaling pathway in astrocytes ameliorates neuronal death and braindamage while reducing behavioral deficits after focal ischemic stroke / H. Li , Y. Xie, N. Zhang [et al.] // Cell Calcium. - 2015. - Vol. 58(6). - Р. 565-576.

82. Doggrell S.A. Treatment of dementia with neurotransmission modulation / S.A.Doggrell, S.Evans // Expert Opin Investig Drugs. - 2003. -N. 12. - P.1633 -1654.

83. Doi Y. A literature review on epidemiologic research on sleep disturbances in the elderly / Y. Doi // Nihon Rinsho. - 2015. - Vol. 73(6). - Р. 895-899.

84. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood / R.F. Storey, L.J. Newby, S. Heptinstall [et al.] // Platelets. - 2001. - Vol.12(7). - Р. 443 - 447.

85. Effects of chronic cerebral hypoperfusion and low-dose progesterone treatment on apoptotic processes, expression and subcellular localization of key elements within Akt and Erk signaling pathways in rat hippocampus / M. Stanojloviж, I. Guљevac, I. Grkoviж [et al.] // Neuroscience. - 2015. - Vol. 311. - Р. 308-321.

86. Exaggerated platelet reactivity to physiological agonists in war veterans with posttraumatic stress disorder / A. Vidoviж, M. Grubiљiж-Iliж, D. Kozariж-Kovaиiж . [et al ]// Psychoneuroendocrinology. -2011. - Vol. 36(2). - P. 161-172.

87. Fanning J.P. The epidemiology of silent brain infarction. - a systematic review of population-based cohorts / J.P. Fanning , A.A. Wong , J.F. Fraser // BMC Med. -2014. - Vol. 9(12). - Р. 119.

88. Finsterwald C. Astrocytes:New Targets for the Treatment of Neurodegenerative Diseases / C. Finsterwald, P.J. Magistretti, S. Lengacher // Curr Pharm Des. -2015. - Vol. 21(25). - Р. 3570-3581.

89. Futosi K. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways / K. Futosi, S. Fodor, A. Mуcsai // Int Immunopharmacol. - 2013. - Vol. 17(4). - Р. 1185 - 1197.

90. Garcia A. Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets/ A. Garcia, H.Shankar, S.Murugappan // Biochem J. -2007. - Vol. 404 ( Pt2). - Р. 299-308.

91. Gatina E.I. Sensitivity to epinephrine determines platelet hyperreactivity in myocardia linfarction under antiplatelet therapy / E.I. Gatina, E.F. Barinov, O.N. Sulaieva, A.M. Gnilorybov // British Journal of Medicine and Medical Research. - 2014. - Vol. 4(29). - Р. 4770-4779.

92. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease. - A Systematic Review and Meta-Analysis of Randomized Controlled Trials / G. Yang, Y. Wang , J. Sun [et al.] // Curr Top Med Chem. - 2016. - Vol. 16(5). - Р. 520-528.

93. Global variation in stroke burdenand mortality: estimates from monitoring, surveillance, and modeling / S.C. Johnston., S. Mendis., C.D Mathers [et al.] // Lancet Neurol. - 2009. - Vol.8(4). - Р.345-354.

94. Gorelick P.B . Advances in vascular cognitive impairment. / Gorelick P.B , Bowler J.V. // Stroke. - 2010. - Vol. 41(2). - Р. 93-98.

95. Gremmel T. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty / T. Gremmel, E. Xhelili, S. Steiner. [et. al.] // Atheroscleros. - 2014. - Vol. 232 (1). - Р. 119 -124.

96. Guidetti G.F. The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets / G.F. Guidetti, P. Lova, B. Bernardi // Biol Chem. - 2008. - Vol. 283(43). - Р. 28795 - 28805.

97. High incidence of stroke in the Brest french stroke population registry, France / S. Timsit, P. Goas, F. Rouhart [et al.] // Abstracts of Cerebrovascular Diseases. - 2011. - Vol. 31. - Р. 2.

98. Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction / C.I. Prodan, J.A. Stoner, L.D. Cowan [et al.] // J Cereb Blood Flow Metab. - 2013. - Vol.33 (2). - Р. 287- 292.

99. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation / J.S. Berger, R.C. Becker, C. Kuhn [et al.] // Thromb Haemost. - 2013. - Vol. 109 (1). - Р. 85-92.

100. Hypertriglyceridemia as a possible predictor of early neurological deterioration in acute lacunar stroke / H. M. Kwon, J. S. Lim, H. K. Park [et al.] // J. Neurol. Sci. - 2011. - Vol. 309(1-2). - P. 128-130.

101. In Vivo Two-photon Fluorescence Microscopy Reveals Disturbed Cerebral Capillary Blood Flow and Increased Susceptibility to Ischemic Insults in Diabetic Mice / J.Y. Huang , L.T. Li, H. Wang [et al.] // CNS Neurosci Ther. - 2014. - Vol. 20 (9). - Р. 816- 822.

102. Independent predictors of ischemic stroke in the elderly: prospective data from a stroke unit / P. Forti, F. Maioli, G. Procaccianti, V. Nativio [et al.] // Neurology. - 2013. - Vol. 80(1). - P. 29-38.

103. Initial 'TTP Map-Defect' of Computed Tomography Perfusion as a Predictor of Hemorrhagic Transformation of Acute Ischemic Stroke / M. Shinoyama, J. Nakagawara, H. Yoneda, M. Suzuki // Cerebrovasc. Dis. Extra. - 2013. - Vol. 3(1). - P. 14-25.

104. Jacobson К. А. Pharmacochemistry of the platelet purinergic receptors / K. A. Jacobson, F. Deflorian, S. Mishra, S. Costanzi // Purinergic Signal. - 2011. - Vоl.7(3). - P. 305-324.

105. Jones S. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation. / S. Jones , R.J. Evans, M.P. Mahaut-Smith // Mol Pharmacol.- 2014. -Vol. 86(3). - P. 243-251.

106. Joo S. J. Mechanisms of Platelet Activation and Integrin бIIв3/ S. J. Joo // Korean Circ J. - 2012. - Vol. 42(5). - Р. 295- 301.

107. Kaplan Z. S. The role of platelets in atherothrombosis / Z. S. Kaplan, S. P. Jackson // Hematol. Am. Soc. Hemat. Educ. Program. - 2011. - Vol. 2011 (1). - Р. 51-61.

108. Kelley B.J. Treatment of mild cognitive impairment / B.J. Kelley // Curr Treat Options Neurol. - 2015. - Vol. 17(9). - Р. 372.

109. Kim D.H. Microvascular and Macrovascular Abnormalities and Cognitive and Physical Function in Older Adults: Cardiovascular Health Study / D.H Kim, F. Grodstein, A.B. Newman // J Am Geriatr Soc.- 2015. -Vol. 63(9).- Р.1886-1993.

110. Kim S. Negative regulation of Gq-mediated pathways in platelets by G(12/13) pathways through Fyn kinase / S. Kim, S.P. Kunapuli // J Biol Chem. - 2011. - Vol. 286(27). - Р. 24170- 24179.

111. Kuriyama N. CD62-mediated activation of platelets in cerebral white matter lesions in patients with cognitive decline / N. Kuriyama, T. Mizuno, H. Yasuike // Arch Gerontol Geriatr. - 2016.- Vol.62.- Р.118-124.

112. Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events / S. Richard , M. Toussaint-Hacquard, R. Fay R. [et al.] // Cerebrovasc Dis.- 2012. -Vol. 33(6). - P. 574-578.

113. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism / R. Carnevale , S. Bartimoccia, C. Nocella [et al]. // Atherosclerosis. - 2014. - Vol. 237(1). - P. 108-116.

114. Lynda L. Stroke risk in women: the role of menopause and hormone therapy / L. Lynda, B. Cheryl // The Lancet Neurology. - 2012. - Vol. 11(1). - Р. 82-91.

115. Monti J.M. The role of nutrition on cognition and brain health in ageing. - a targeted approach / J.M. Monti, C.J. Moulton, N.J. Cohen // Nutr Res Rev. - 2015. - Vol. 28(2). - Р. 167-180.

116. Nair M. Platelets Contribute to BBB Disruption Induced by HIV and Alcohol / M. Nair, J.M. Maria, M. Agudelo // J Alcohol Drug Depend. - 2015. - Vol. 3(1). - Р. 182.

117. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards / Hachinski V., Iadecola C., Peterson R.C. [et al] // Stroke. - 2006. - Vol 37 (9). - Р. 2220-2241

118. Nieswandt B. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke/ B. Nieswandt, I. Pleines, M. Bender // J Thromb Haemost. - 2011. - Vol.9 (1). - Р. 92-104.

119. Ohira H. Polymorphism of the serotonin transporter gene modulates brain and physiological responses to acute stress in Japanese men / H.Ohira // Stress. - 2009. - Vol. 12(6). - Р. 533-543.

120. Ombrello C. Our expanding view of platelet functions and its clinical implications / C. Ombrello, R. C. Block, C. N. Morrell // J. Cardiovasc. Transl. Res. - 2010. - Vol. 3(5). - P. 538 -546.

121. Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study / A.J. Lawrence, R.L. Brookes, E.A. Zeestraten [et al.] // PLoS One. - 2015. - Vol. 10(8). - e0135523.

122. Petersen R.Consensus on mild cognitive impairment. Research Prevention and management of stroke in very elderly patients / R. Petersen, J.Touchon // The Lancet Neurology. - 2009. - Vol. 8(11). - Р. 1031-1041.

123. Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia / L.M. Soares, J. Prickaerts, H. Milani [et al.] // CNS Neurol Disord Drug Targets. - 2015. - Vol. 14(8). -Р 1012-1023.

124. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease / P.R. Manzine, E.J. Barham, F.A. Vale [et al.] // Int J Geriatr Psychiatry.- 2014.- Vol. 29(4). - P. 414-420.

125. Platelets and acute cerebral infarction / Jдremo P., Eriksson M., Lindahl T.L. [et al.] // Platelets. - 2013. - Vol. 24(5). - Р. 407-411.

126. Profiles of the National Institutes of Health Stroke Scale Items as a Predictor of Patient Outcome / H. Sucharew, J. Khoury, C. J. Moomaw [et al.] // Stroke. - 2013. - Vol. 44(5). - P. 1081-1086.

127. Progression of asymptomatic carotid stenosis despite optimal medical therapy / M.F. Conrad , V. Boulom , S. Mukhopadhyay [et al.] // J Vasc Surg. - 2013. - Vol. 58(1). - Р. 128-135.

128. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials / T. Kishi, S. Matsunaga, K. Oya [et al.] // Int J Neuropsychopharmacol. - 2015. - Vol. 18(12). - pyv070.

129. Rap1-Rac1 circuits potentiate platelet activation / L. Stefanini, Y. Boulaftali, T. D. Ouellette [et al.] // Arterioscler Thromb Vasc Biol. -2012. - Vol. 32(2). - Р. 434- 441.

130. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs / D.E Thaler ., R Ruthazer ., C Weimar [et al.] // Neurology. - 2014. - Vol. 83(3). - P. 221-226.

131. Regulators of platelet cAMP levels. - clinical and therapeutic implications / L. Noй, K. Peeters, B. Izzi [et al.] // Curr. Med. Chem. - 2010. - Vol. 17(26). - P. 2897-2905.

132. Remote ischaemic conditioning-a new paradigm of self-protection in the brain / D.C. Hess, R.A. Blauenfeldt, G. Andersen [et al.] // Nat Rev Neurol. - 2015. - Vol. 11(12).- Р. 698-710.

133. Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events /S. Richard, M.Toussaint-Hacquard, R.Fay [et al.] // Cerebrovasc Dis. - 2012. - Vol. 33(6).- P. 574-578.

134. Risk factors and acute ischemic stroke subtypes / A. Kisialiou, R. Grella, A. Carrizzo [et al.] // J Neurol Sci.-2014. - Vol. 339( 1-2). - P. 41-46.

135. Rodrigues S.F. Blood cells and endothelial barrier function / S.F Rodrigues, D.N Granger // Tissue Barriers. - 2015. - Vol. 3(1-2). - e978720.

136. Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatric depression / D. Steffens, W. Taylor, D.McQuoid [et al.] // Int J Geriatr Psychiatry. - 2008. - Vol. 23 (3). - Р. 244-248.

137. Simon M.J. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease / M.J. Simon, J.J. Iliff // Biochim Biophys Acta. - 2015 Oct 22. pii. - S0925-4439(15)00314-2.

138. Status of carotid intima-media thickness and associated risk factors in diabetic, prediabetic and non-diabetic acute stroke / U.S. Ghosh, P. Chattopadhyay, S. Banerjee [et al.] // J. Assoc. Physicians India. - 2012. - Vol. 60. - P. 26-32.

139. Stroke and thromboembolism in atrial fibrillation / R. Pisters, D. A. Lane, F. Marin, A. J. Camm // Circ. J. - 2012. - Vol. 76(10). - P. 2289-2304.

140. Subcortical ischemic vascular dementia / G.C. Roman, T. Erkinjuntti, A. Wallin [et al.] // Lancet Neurology. - 2002. - Vol. 1. - P. 426-436.

141. Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients / Y. Yano, S. Hoshide, T. Etoh [et al]. // Atherosclerosis. - 2011. - Vol. 219(1). - Р. 273-279.

142. Tanahashi N. Antiplatelet therapy for secondary prevention of cerebral infarction / N. Tanahashi // Nihon Rinsho. - 2014. - Vol. 72(7). - Р. 1270-1275.

143. Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis / K. Przyklenk, A. L. Frelinger, M. D. Linden [et al.] // J. Thromb. Haemost. - 2010. - Vol. 8(2). - P. 331-340.

144. The Efficacy of Cognitive Intervention Programs for Mild Cognitive Impairment: A Systematic Review / Y.J. Hong, E.H. Jang, J. Hwang [et al.] // Curr Alzheimer Res. - 2015. - Vol.12(6). - Р. 527-542.

145. The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets / G.F. Guidetti, P. Lova, B. Bernardi B. [et al] // J Biol Chem. -2008. - Vol. 283(43). - P. 28795-28805.

146. The meaning of cognitive impairment in the elderly / Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM // J Am Geriatr Soc.- 1985. - Vоl. 33(4). - Р. 228-235.

147. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects / N.A. Alarayyed, B.R. Graham, B.N. Prichard, C.C. Smith // Br J clin Pharmac. - 1995. - N. 39. - Р. 369-374.

148. The role of platelets and their microparticles in rehabilitation of ischemic brain tissue / Y. Hayon, E. Shai, D. Varon [et al.] // CNS Neurol Disord Drug Targets. - 2012. - Vol.11(7). - Р.921-925.

149. Time-trends in case fatality after stroke: analyses of data from the south London stroke register: C.D.A. United Kingdom. 20th European Stroke Conference. Abstracts Hamburg, Germane / J.Addo, A.Bhalla, S.Crichton, C.McKevitt [ et al.] // Cerebrovascular Diseases. - 2011. - Vol. 31. - Р. 2.

150. Tobin W.O. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study / W.O. Tobin, J.A. Kinsella, D.R. Collins // Br J Haematol. - 2011. - Vol. 152 (5). - Р. 640-647.

151. Total MRI load of cerebral small vessel disease and cognitive ability in older people / J. Staals, T. Booth, Z. Morris [et al.] // Neurobiol Aging.- 2015. - Vol. 36(10). - Р. 2806-2811.

152. Transcranial Doppler sonography: anatomical landmarks and normal velocity values / E.B. Ringelstein, В. Kahlscheuer, Е. Niggemeyer, S.M. Otis // Ultrasound Med Biol. - 1990. - Vol.6(8). -Р. 745-761.

153. Treatment of Cognitive Deficits in Genetic Disorders. - A Systematic Review of Clinical Trials of Diet and Drug Treatments/ T. van der Vaart, I.E. Overwater, R. Oostenbrink [et al.] // JAMA Neurol. - 2015. - Vol. 72(9). - Р. 1052-1060.

154. Van Der Spuy W. J. Interrelation between inflammation, thrombosis, and neuroprotection in cerebral ischemia/ W. J. Van Der Spuy, E. Pretorius // Rev. Neurosci. - 2012. - Vol. 23(3). - P. 269-278.

155. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints / A.Kearney-Schwartz, P.Rossignol, S.Bracard [et al.] // Stroke. - 2009. - Vol. 40(4). - P. 1229-1236.

156. Velayudhan L. Risk of developing dementia in people with diabetes and mild cognitive impairment / L. Velayudhan, M. Poppe, N. Archer // BJP. - 2010. - Vol. 196(1). - Р. 36-40.

157. White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline / M.R. Benedictus, A.C. van Harten, A.E. Leeuwis [et al.] // Stroke. - 2015. - Vol. 46(9). - Р. 2661-2664.

158. Woollard K. J. Immunological aspects of atherosclerosis / K. J. Woollard // Clin Sci (Lond). - 2013. - Vol. 125(5). - Р. 221 -235.

159. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review / V.L.Feigin, C.M.Lawes, D.A. Bennett [et al.] // Lancet Neurol. - 2009. - Vol. 8(4). - Р.355-369.

160. Zhang W.Contribution of blood platelets to vascular pathology in Alzheimer's disease / W. Zhang, W. Huang, F. Jing // J Blood Med.- 2013. - Vol. 8 (4). - Р. 141-147.

Размещено на Allbest.ru

...

Подобные документы

Работы в архивах красиво оформлены согласно требованиям ВУЗов и содержат рисунки, диаграммы, формулы и т.д.
PPT, PPTX и PDF-файлы представлены только в архивах.
Рекомендуем скачать работу.